Serial Number 97370080
733

Registration Progress

Application Filed
Apr 19, 2022
Under Examination
Sep 12, 2023
Approved for Publication
Jul 18, 2023
Published for Opposition
Jul 18, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Mar 12, 2026 245 days

Trademark Image

Basic Information

Serial Number
97370080
Deadline
March 12, 2026
Description
Statement of Use or 5th Extension Due
Filing Date
April 19, 2022
Published for Opposition
July 18, 2023
Drawing Code
2

Status Summary

Current Status
Active
Status Code
733
Status Date
Mar 25, 2025
Application
Pending
Classes
005 042

Rights Holder

Triana Biomedicines, Inc.

03
Address
1050 Waltham St, Suite 301
Lexington, MA 02421

Ownership History

Triana Biomedicines, Inc.

Original Applicant
03
Waltham, MA

Triana Biomedicines, Inc.

Owner at Publication
03
Lexington, MA

Legal Representation

Attorney
Susan Weller

USPTO Deadlines

Next Deadline
245 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
March 12, 2026
Extension Available
Until September 12, 2024

Application History

33 events
Date Code Type Description
Mar 26, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 25, 2025 EX4G S SOU EXTENSION 4 GRANTED
Mar 25, 2025 EXT4 S SOU EXTENSION 4 FILED
Mar 25, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 16, 2024 EXT3 S SOU EXTENSION 3 FILED
Dec 16, 2024 EX3G S SOU EXTENSION 3 GRANTED
Dec 16, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 19, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2024 EXT2 S SOU EXTENSION 2 FILED
Aug 19, 2024 EX2G S SOU EXTENSION 2 GRANTED
Aug 19, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 2, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 31, 2024 EXT1 S SOU EXTENSION 1 FILED
Jan 31, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 31, 2024 EX1G S SOU EXTENSION 1 GRANTED
Sep 12, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 18, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 18, 2023 PUBO A PUBLISHED FOR OPPOSITION
Jun 28, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 9, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 7, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 7, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 31, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 31, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 9, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 9, 2022 GNRT F NON-FINAL ACTION E-MAILED
Dec 9, 2022 CNRT R NON-FINAL ACTION WRITTEN
Dec 6, 2022 DOCK D ASSIGNED TO EXAMINER
Apr 27, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 26, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases
Class 042
research and development in the field of small molecule medicines for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases; scientific research in the nature of conducting medical and scientific research, namely, conducting clinical trials for others in the field of small molecule medicines for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases

Additional Information

Design Mark
The mark consists of three shaded circles connected by three sperate sets of curved lines to form a triangle.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 042